<VariationArchive VariationID="371213" VariationName="NM_005476.7(GNE):c.636dup (p.Asp213fs)" VariationType="Duplication" Accession="VCV000371213" Version="8" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-28" DateCreated="2017-01-06" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="357803" VariationID="371213">
      <GeneList>
        <Gene Symbol="GNE" FullName="glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase" GeneID="10020" HGNC_ID="HGNC:23657" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="36214441" stop="36276978" display_start="36214441" display_stop="36276978" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="36214437" stop="36277052" display_start="36214437" display_stop="36277052" Strand="-" />
          </Location>
          <OMIM>603824</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_005476.7(GNE):c.636dup (p.Asp213fs)</Name>
      <CanonicalSPDI>NC_000009.12:36236964:TTT:TTTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>9p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="36236964" stop="36236965" display_start="36236964" display_stop="36236965" variantLength="1" positionVCF="36236964" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="36236961" stop="36236962" display_start="36236961" display_stop="36236962" variantLength="1" positionVCF="36236961" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <ProteinChange>D213fs</ProteinChange>
      <ProteinChange>D244fs</ProteinChange>
      <ProteinChange>D154fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001128227.2" sequenceAccession="NM_001128227" sequenceVersion="2" change="c.729dup">
            <Expression>NM_001128227.2:c.729dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.36236964dup" Assembly="GRCh37">
            <Expression>NC_000009.11:g.36236964dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.36236967dup" Assembly="GRCh38">
            <Expression>NC_000009.12:g.36236967dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008246.1" sequenceAccession="NG_008246" sequenceVersion="1" change="g.45080dup">
            <Expression>NG_008246.1:g.45080dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001128227.3" sequenceAccession="NM_001128227" sequenceVersion="3" change="c.729dup" MANEPlusClinical="true">
            <Expression>NM_001128227.3:c.729dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121699.1" sequenceAccession="NP_001121699" sequenceVersion="1" change="p.Asp244fs">
            <Expression>NP_001121699.1:p.Asp244fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001190383.3" sequenceAccession="NM_001190383" sequenceVersion="3" change="c.636dup">
            <Expression>NM_001190383.3:c.636dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001177312.1" sequenceAccession="NP_001177312" sequenceVersion="1" change="p.Asp213fs">
            <Expression>NP_001177312.1:p.Asp213fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001190388.2" sequenceAccession="NM_001190388" sequenceVersion="2" change="c.459dup">
            <Expression>NM_001190388.2:c.459dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001177317.2" sequenceAccession="NP_001177317" sequenceVersion="2" change="p.Asp154fs">
            <Expression>NP_001177317.2:p.Asp154fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374798.1" sequenceAccession="NM_001374798" sequenceVersion="1" change="c.459dup">
            <Expression>NM_001374798.1:c.459dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001361727.1" sequenceAccession="NP_001361727" sequenceVersion="1" change="p.Asp154fs">
            <Expression>NP_001361727.1:p.Asp154fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005476.7" sequenceAccession="NM_005476" sequenceVersion="7" change="c.636dup" MANESelect="true">
            <Expression>NM_005476.7:c.636dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005467.1" sequenceAccession="NP_005467" sequenceVersion="1" change="p.Asp213fs">
            <Expression>NP_005467.1:p.Asp213fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001190384.3" sequenceAccession="NM_001190384" sequenceVersion="3" change="c.440-2835dup">
            <Expression>NM_001190384.3:c.440-2835dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374797.1" sequenceAccession="NM_001374797" sequenceVersion="1" change="c.617-2835dup">
            <Expression>NM_001374797.1:c.617-2835dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1197" sequenceAccession="LRG_1197">
            <Expression>LRG_1197:g.45080dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1197t1" sequenceAccession="LRG_1197t1">
            <Expression>LRG_1197t1:c.729dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1197p1" sequenceAccession="LRG_1197p1" change="p.Asp244fs">
            <Expression>LRG_1197p1:p.Asp244fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1197t2" sequenceAccession="LRG_1197t2">
            <Expression>LRG_1197t2:c.636dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1197p2" sequenceAccession="LRG_1197p2" change="p.Asp213fs">
            <Expression>LRG_1197p2:p.Asp213fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA16041321" DB="ClinGen" />
        <XRef Type="rs" ID="1057517094" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005476.7(GNE):c.636dup (p.Asp213fs) AND GNE myopathy" Accession="RCV000410658" Version="3">
        <ClassifiedConditionList TraitSetID="1671">
          <ClassifiedCondition DB="MedGen" ID="C1853926">GNE myopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-05-18" SubmissionCount="2">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_005476.7(GNE):c.636dup (p.Asp213fs) AND multiple conditions" Accession="RCV001215762" Version="5">
        <ClassifiedConditionList TraitSetID="10251">
          <ClassifiedCondition DB="MedGen" ID="C1853926">GNE myopathy</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0342853">Sialuria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-02-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-18" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2017-01-06" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16503651</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24027297</ID>
        </Citation>
        <DescriptionHistory Dated="2020-07-15">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="10251" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3097" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Nonaka myopathy</ElementValue>
                <XRef ID="Nonaka+myopathy/5252" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nonaka distal myopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">INCLUSION BODY MYOPATHY, HEREDITARY, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INCLUSION BODY MYOPATHY 2, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="600737" DB="OMIM" />
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MYOPATHY, DISTAL, WITH OR WITHOUT RIMMED VACUOLES</ElementValue>
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Inclusion body myopathy 2</ElementValue>
                <XRef ID="Inclusion+body+myopathy+2/3793" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">IBM 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Inclusion body myopathy autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Inclusion body myopathy quadriceps sparing</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">GNE myopathy</ElementValue>
                <XRef ID="224171" DB="GeneTests" />
                <XRef ID="MONDO:0011603" DB="MONDO" />
                <XRef ID="602" DB="Orphanet" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HIBM</ElementValue>
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">QSM</ElementValue>
                <XRef Type="MIM" ID="600737" DB="OMIM" />
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IBM2</ElementValue>
                <XRef Type="MIM" ID="605820" DB="OMIM" />
                <XRef Type="MIM" ID="600737" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">NM</ElementValue>
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9493" />
                <XRef ID="9493" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">GNE myopathy is a slowly progressive muscle disease that typically presents between age 20 and 40 years with bilateral foot drop caused by anterior tibialis weakness. Lower-extremity muscle involvement progresses from the anterior to the posterior compartment of the lower leg, followed by hamstrings, then hip girdle muscles, with relative sparing of the quadriceps. A wheelchair may be needed about ten to 20 years after the onset of manifestations. The upper extremities, which may be affected within five to ten years of disease onset, do not necessarily follow a distal-to-proximal progression. In advanced stages, neck and core muscles can become affected.</Attribute>
                <XRef ID="NBK1262" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">GNE-Related Myopathy</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301439</ID>
                <ID Source="BookShelf">NBK1262</ID>
              </Citation>
              <XRef ID="602" DB="Orphanet" />
              <XRef ID="C1853926" DB="MedGen" />
              <XRef ID="MONDO:0011603" DB="MONDO" />
              <XRef Type="MIM" ID="605820" DB="OMIM" />
            </Trait>
            <Trait ID="3728" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Sialic Acid Storage Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sialuria, French type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Sialuria</ElementValue>
                <XRef ID="21151" DB="GeneTests" />
                <XRef ID="Sialuria%2C+French+type/6588" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010028" DB="MONDO" />
                <XRef ID="238051008" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4865" />
                <XRef ID="4865" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="3166" DB="Orphanet" />
              <XRef ID="C0342853" DB="MedGen" />
              <XRef ID="MONDO:0010028" DB="MONDO" />
              <XRef Type="MIM" ID="269921" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1671" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3097" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Nonaka myopathy</ElementValue>
                <XRef ID="Nonaka+myopathy/5252" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nonaka distal myopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">INCLUSION BODY MYOPATHY, HEREDITARY, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INCLUSION BODY MYOPATHY 2, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="600737" DB="OMIM" />
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MYOPATHY, DISTAL, WITH OR WITHOUT RIMMED VACUOLES</ElementValue>
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Inclusion body myopathy 2</ElementValue>
                <XRef ID="Inclusion+body+myopathy+2/3793" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">IBM 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Inclusion body myopathy autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Inclusion body myopathy quadriceps sparing</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">GNE myopathy</ElementValue>
                <XRef ID="224171" DB="GeneTests" />
                <XRef ID="MONDO:0011603" DB="MONDO" />
                <XRef ID="602" DB="Orphanet" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HIBM</ElementValue>
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">QSM</ElementValue>
                <XRef Type="MIM" ID="600737" DB="OMIM" />
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IBM2</ElementValue>
                <XRef Type="MIM" ID="605820" DB="OMIM" />
                <XRef Type="MIM" ID="600737" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">NM</ElementValue>
                <XRef Type="MIM" ID="605820" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9493" />
                <XRef ID="9493" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">GNE myopathy is a slowly progressive muscle disease that typically presents between age 20 and 40 years with bilateral foot drop caused by anterior tibialis weakness. Lower-extremity muscle involvement progresses from the anterior to the posterior compartment of the lower leg, followed by hamstrings, then hip girdle muscles, with relative sparing of the quadriceps. A wheelchair may be needed about ten to 20 years after the onset of manifestations. The upper extremities, which may be affected within five to ten years of disease onset, do not necessarily follow a distal-to-proximal progression. In advanced stages, neck and core muscles can become affected.</Attribute>
                <XRef ID="NBK1262" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">GNE-Related Myopathy</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301439</ID>
                <ID Source="BookShelf">NBK1262</ID>
              </Citation>
              <XRef ID="602" DB="Orphanet" />
              <XRef ID="C1853926" DB="MedGen" />
              <XRef ID="MONDO:0011603" DB="MONDO" />
              <XRef Type="MIM" ID="605820" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="950487" SubmissionDate="2016-11-23" DateLastUpdated="2022-12-24" DateCreated="2017-01-06">
        <ClinVarSubmissionID localKey="995097|OMIM:600737" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000486737" DateUpdated="2022-12-24" DateCreated="2017-01-06" Type="SCV" Version="2" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-07-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16503651</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rb7nm21v/ar_xl2015criteria.pdf</URL>
            <CitationText>mdi-5618_320494_Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015).pdf</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GNE" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001128227.2:c.729dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="600737" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Counsyl2016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7846106" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_001128227.2:c.729dup|OMIM:605820" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004191646" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001128227.2:c.729dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605820" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2722358" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="7379307|MedGen:C0342853;C1833373" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001387524" DateUpdated="2024-02-28" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-02-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24027297</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in GNE are known to be pathogenic (PMID: 24027297). This variant has not been reported in the literature in individuals with GNE-related conditions. ClinVar contains an entry for this variant (Variation ID: 371213). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Asp244Argfs*13) in the GNE gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GNE" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.36236961_36236962insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0342853" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1833373" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7846106" TraitType="Disease" MappingType="XRef" MappingValue="605820" MappingRef="OMIM">
        <MedGen CUI="C1853926" Name="GNE myopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="950487" TraitType="Disease" MappingType="XRef" MappingValue="600737" MappingRef="OMIM">
        <MedGen CUI="C1853926" Name="GNE myopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2722358" TraitType="Disease" MappingType="XRef" MappingValue="C1833373" MappingRef="MedGen">
        <MedGen CUI="C1853926" Name="GNE myopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2722358" TraitType="Disease" MappingType="XRef" MappingValue="C0342853" MappingRef="MedGen">
        <MedGen CUI="C0342853" Name="Sialuria" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

